Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-16

Clinical Trial Update: Fermented Iron-rich Supplement in Reducing Anemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Ghana is evaluating a fermented iron-rich supplement for reducing iron deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fermented Iron-rich Supplement

Snippet

Sponsor: University of Ghana | Conditions: Iron Deficiency Anemia | Phase 2 | Status: UNKNOWN